nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentolamine—Post procedural pain—Mycophenolic acid—systemic scleroderma	0.104	0.104	CcSEcCtD
Phentolamine—Procedural pain—Mycophenolic acid—systemic scleroderma	0.0383	0.0383	CcSEcCtD
Phentolamine—Hypotensive—Captopril—systemic scleroderma	0.0381	0.0381	CcSEcCtD
Phentolamine—Peptic ulcer—Captopril—systemic scleroderma	0.0208	0.0208	CcSEcCtD
Phentolamine—Peptic ulcer—Mycophenolic acid—systemic scleroderma	0.0164	0.0164	CcSEcCtD
Phentolamine—Nasal congestion—Pentoxifylline—systemic scleroderma	0.0146	0.0146	CcSEcCtD
Phentolamine—Blood pressure increased—Captopril—systemic scleroderma	0.0139	0.0139	CcSEcCtD
Phentolamine—Peptic ulcer—Mycophenolate mofetil—systemic scleroderma	0.0129	0.0129	CcSEcCtD
Phentolamine—Nasal congestion—Mometasone—systemic scleroderma	0.0126	0.0126	CcSEcCtD
Phentolamine—Blood pressure increased—Leflunomide—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Phentolamine—Angina pectoris—Pentoxifylline—systemic scleroderma	0.0112	0.0112	CcSEcCtD
Phentolamine—Blood pressure increased—Mycophenolic acid—systemic scleroderma	0.0109	0.0109	CcSEcCtD
Phentolamine—Orthostatic hypotension—Captopril—systemic scleroderma	0.00923	0.00923	CcSEcCtD
Phentolamine—Peptic ulcer—Prednisone—systemic scleroderma	0.00876	0.00876	CcSEcCtD
Phentolamine—Injection site reaction—Mycophenolate mofetil—systemic scleroderma	0.00858	0.00858	CcSEcCtD
Phentolamine—Flushing—Pentoxifylline—systemic scleroderma	0.00856	0.00856	CcSEcCtD
Phentolamine—Angina pectoris—Captopril—systemic scleroderma	0.0085	0.0085	CcSEcCtD
Phentolamine—Arrhythmia—Pentoxifylline—systemic scleroderma	0.00824	0.00824	CcSEcCtD
Phentolamine—Nasal congestion—Lisinopril—systemic scleroderma	0.00785	0.00785	CcSEcCtD
Phentolamine—Orthostatic hypotension—Mycophenolic acid—systemic scleroderma	0.00725	0.00725	CcSEcCtD
Phentolamine—Abdominal pain upper—Mycophenolic acid—systemic scleroderma	0.00725	0.00725	CcSEcCtD
Phentolamine—Mediastinal disorder—Mometasone—systemic scleroderma	0.00717	0.00717	CcSEcCtD
Phentolamine—Angina pectoris—Leflunomide—systemic scleroderma	0.00701	0.00701	CcSEcCtD
Phentolamine—Hypertension—Pentoxifylline—systemic scleroderma	0.00693	0.00693	CcSEcCtD
Phentolamine—Chest pain—Pentoxifylline—systemic scleroderma	0.00683	0.00683	CcSEcCtD
Phentolamine—Angina pectoris—Mycophenolic acid—systemic scleroderma	0.00669	0.00669	CcSEcCtD
Phentolamine—Orthostatic hypotension—Lisinopril—systemic scleroderma	0.00653	0.00653	CcSEcCtD
Phentolamine—Flushing—Captopril—systemic scleroderma	0.00649	0.00649	CcSEcCtD
Phentolamine—Tachycardia—Pentoxifylline—systemic scleroderma	0.00639	0.00639	CcSEcCtD
Phentolamine—Hypotension—Pentoxifylline—systemic scleroderma	0.00612	0.00612	CcSEcCtD
Phentolamine—Angina pectoris—Lisinopril—systemic scleroderma	0.00602	0.00602	CcSEcCtD
Phentolamine—Chest pain—Mometasone—systemic scleroderma	0.0059	0.0059	CcSEcCtD
Phentolamine—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.00572	0.00572	CcSEcCtD
Phentolamine—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00559	0.00559	CcSEcCtD
Phentolamine—Mediastinal disorder—Azathioprine—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Phentolamine—Arrhythmia—Azathioprine—systemic scleroderma	0.00545	0.00545	CcSEcCtD
Phentolamine—Acute coronary syndrome—Lisinopril—systemic scleroderma	0.00543	0.00543	CcSEcCtD
Phentolamine—Myocardial infarction—Lisinopril—systemic scleroderma	0.0054	0.0054	CcSEcCtD
Phentolamine—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.00536	0.00536	CcSEcCtD
Phentolamine—Cardiac disorder—Leflunomide—systemic scleroderma	0.00535	0.00535	CcSEcCtD
Phentolamine—Angina pectoris—Mycophenolate mofetil—systemic scleroderma	0.00528	0.00528	CcSEcCtD
Phentolamine—Mediastinal disorder—Leflunomide—systemic scleroderma	0.00519	0.00519	CcSEcCtD
Phentolamine—Chest pain—Captopril—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Phentolamine—Abdominal pain—Pentoxifylline—systemic scleroderma	0.00518	0.00518	CcSEcCtD
Phentolamine—Arrhythmia—Leflunomide—systemic scleroderma	0.00515	0.00515	CcSEcCtD
Phentolamine—Cardiac disorder—Mycophenolic acid—systemic scleroderma	0.0051	0.0051	CcSEcCtD
Phentolamine—Paraesthesia—Mometasone—systemic scleroderma	0.00508	0.00508	CcSEcCtD
Phentolamine—Bradycardia—Lisinopril—systemic scleroderma	0.00504	0.00504	CcSEcCtD
Phentolamine—Angiopathy—Mycophenolic acid—systemic scleroderma	0.00499	0.00499	CcSEcCtD
Phentolamine—Mediastinal disorder—Mycophenolic acid—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Phentolamine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00491	0.00491	CcSEcCtD
Phentolamine—Tachycardia—Captopril—systemic scleroderma	0.00485	0.00485	CcSEcCtD
Phentolamine—Pain—Mometasone—systemic scleroderma	0.00483	0.00483	CcSEcCtD
Phentolamine—Acute coronary syndrome—Mycophenolate mofetil—systemic scleroderma	0.00476	0.00476	CcSEcCtD
Phentolamine—Myocardial infarction—Mycophenolate mofetil—systemic scleroderma	0.00473	0.00473	CcSEcCtD
Phentolamine—Asthenia—Pentoxifylline—systemic scleroderma	0.0047	0.0047	CcSEcCtD
Phentolamine—Hypotension—Captopril—systemic scleroderma	0.00464	0.00464	CcSEcCtD
Phentolamine—Pruritus—Pentoxifylline—systemic scleroderma	0.00464	0.00464	CcSEcCtD
Phentolamine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00462	0.00462	CcSEcCtD
Phentolamine—Flushing—Lisinopril—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Phentolamine—Angiopathy—Lisinopril—systemic scleroderma	0.00449	0.00449	CcSEcCtD
Phentolamine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Phentolamine—Abdominal pain—Mometasone—systemic scleroderma	0.00447	0.00447	CcSEcCtD
Phentolamine—Mediastinal disorder—Lisinopril—systemic scleroderma	0.00446	0.00446	CcSEcCtD
Phentolamine—Paraesthesia—Captopril—systemic scleroderma	0.00446	0.00446	CcSEcCtD
Phentolamine—Arrhythmia—Lisinopril—systemic scleroderma	0.00442	0.00442	CcSEcCtD
Phentolamine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00441	0.00441	CcSEcCtD
Phentolamine—Dizziness—Pentoxifylline—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Phentolamine—Hypertension—Leflunomide—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Phentolamine—Chest pain—Leflunomide—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Phentolamine—Vomiting—Pentoxifylline—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Phentolamine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00413	0.00413	CcSEcCtD
Phentolamine—Headache—Pentoxifylline—systemic scleroderma	0.0041	0.0041	CcSEcCtD
Phentolamine—Chest pain—Mycophenolic acid—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Phentolamine—Gastrointestinal pain—Captopril—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Phentolamine—Asthenia—Mometasone—systemic scleroderma	0.00406	0.00406	CcSEcCtD
Phentolamine—Hypotension—Azathioprine—systemic scleroderma	0.00405	0.00405	CcSEcCtD
Phentolamine—Cardiac disorder—Mycophenolate mofetil—systemic scleroderma	0.00402	0.00402	CcSEcCtD
Phentolamine—Nervous system disorder—Leflunomide—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Phentolamine—Pruritus—Mometasone—systemic scleroderma	0.004	0.004	CcSEcCtD
Phentolamine—Tachycardia—Leflunomide—systemic scleroderma	0.00399	0.00399	CcSEcCtD
Phentolamine—Angiopathy—Mycophenolate mofetil—systemic scleroderma	0.00393	0.00393	CcSEcCtD
Phentolamine—Abdominal pain—Captopril—systemic scleroderma	0.00392	0.00392	CcSEcCtD
Phentolamine—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00391	0.00391	CcSEcCtD
Phentolamine—Nausea—Pentoxifylline—systemic scleroderma	0.00389	0.00389	CcSEcCtD
Phentolamine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00387	0.00387	CcSEcCtD
Phentolamine—Diarrhoea—Mometasone—systemic scleroderma	0.00387	0.00387	CcSEcCtD
Phentolamine—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.00383	0.00383	CcSEcCtD
Phentolamine—Hypotension—Leflunomide—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Phentolamine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Phentolamine—Paraesthesia—Leflunomide—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Phentolamine—Chest pain—Lisinopril—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Phentolamine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00365	0.00365	CcSEcCtD
Phentolamine—Vomiting—Mometasone—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Phentolamine—Asthenia—Captopril—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Phentolamine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Phentolamine—Headache—Mometasone—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Phentolamine—Pruritus—Captopril—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Phentolamine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00351	0.00351	CcSEcCtD
Phentolamine—Pain—Leflunomide—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Phentolamine—Tachycardia—Lisinopril—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Phentolamine—Abdominal pain—Azathioprine—systemic scleroderma	0.00343	0.00343	CcSEcCtD
Phentolamine—Diarrhoea—Captopril—systemic scleroderma	0.0034	0.0034	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Phentolamine—Nausea—Mometasone—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Phentolamine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Phentolamine—Pain—Mycophenolic acid—systemic scleroderma	0.00334	0.00334	CcSEcCtD
Phentolamine—Hypotension—Lisinopril—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Phentolamine—Dizziness—Captopril—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Phentolamine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Phentolamine—Abdominal pain—Leflunomide—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Phentolamine—Acute coronary syndrome—Prednisone—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Phentolamine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Phentolamine—Myocardial infarction—Prednisone—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Phentolamine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Phentolamine—Paraesthesia—Lisinopril—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Phentolamine—Vomiting—Captopril—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Phentolamine—Headache—Captopril—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Phentolamine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Phentolamine—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Phentolamine—Pain—Lisinopril—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Phentolamine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00301	0.00301	CcSEcCtD
Phentolamine—Bradycardia—Prednisone—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Phentolamine—Diarrhoea—Azathioprine—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Phentolamine—Nausea—Captopril—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Phentolamine—Asthenia—Leflunomide—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Phentolamine—Pruritus—Leflunomide—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Phentolamine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Phentolamine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Phentolamine—Dizziness—Azathioprine—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Phentolamine—Asthenia—Mycophenolic acid—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Phentolamine—Diarrhoea—Leflunomide—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Phentolamine—Abdominal pain—Lisinopril—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Phentolamine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Phentolamine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Phentolamine—Vomiting—Azathioprine—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Phentolamine—Flushing—Prednisone—systemic scleroderma	0.00273	0.00273	CcSEcCtD
Phentolamine—Headache—Azathioprine—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Phentolamine—Dizziness—Leflunomide—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Phentolamine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Phentolamine—Angiopathy—Prednisone—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Phentolamine—Pain—Mycophenolate mofetil—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Phentolamine—Arrhythmia—Prednisone—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Phentolamine—Vomiting—Leflunomide—systemic scleroderma	0.0026	0.0026	CcSEcCtD
Phentolamine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Phentolamine—Nausea—Azathioprine—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Phentolamine—Headache—Leflunomide—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Phentolamine—Asthenia—Lisinopril—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Phentolamine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Phentolamine—Pruritus—Lisinopril—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Phentolamine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00248	0.00248	CcSEcCtD
Phentolamine—Headache—Mycophenolic acid—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Phentolamine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Phentolamine—Nausea—Leflunomide—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Phentolamine—Diarrhoea—Lisinopril—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Phentolamine—Dizziness—Lisinopril—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Phentolamine—Nausea—Mycophenolic acid—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Phentolamine—Cardiac disorder—Methotrexate—systemic scleroderma	0.00228	0.00228	CcSEcCtD
Phentolamine—Vomiting—Lisinopril—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Phentolamine—Angiopathy—Methotrexate—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Phentolamine—Mediastinal disorder—Methotrexate—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Phentolamine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Phentolamine—Hypertension—Prednisone—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Phentolamine—Headache—Lisinopril—systemic scleroderma	0.0022	0.0022	CcSEcCtD
Phentolamine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Phentolamine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.00211	0.00211	CcSEcCtD
Phentolamine—Nausea—Lisinopril—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Phentolamine—Nervous system disorder—Prednisone—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Phentolamine—Tachycardia—Prednisone—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Phentolamine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Phentolamine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Phentolamine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Phentolamine—Paraesthesia—Prednisone—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Phentolamine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Phentolamine—Chest pain—Methotrexate—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Phentolamine—Nervous system disorder—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Phentolamine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Phentolamine—Abdominal pain—Prednisone—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Phentolamine—Hypotension—Methotrexate—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Phentolamine—Paraesthesia—Methotrexate—systemic scleroderma	0.00157	0.00157	CcSEcCtD
Phentolamine—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Phentolamine—Asthenia—Prednisone—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Phentolamine—Pain—Methotrexate—systemic scleroderma	0.00149	0.00149	CcSEcCtD
Phentolamine—Pruritus—Prednisone—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Phentolamine—Diarrhoea—Prednisone—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Phentolamine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Phentolamine—Dizziness—Prednisone—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Phentolamine—Abdominal pain—Methotrexate—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Phentolamine—Vomiting—Prednisone—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Phentolamine—Headache—Prednisone—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Phentolamine—Asthenia—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Phentolamine—Nausea—Prednisone—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Phentolamine—Pruritus—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Phentolamine—Diarrhoea—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Phentolamine—Dizziness—Methotrexate—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Phentolamine—Vomiting—Methotrexate—systemic scleroderma	0.00111	0.00111	CcSEcCtD
Phentolamine—Headache—Methotrexate—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Phentolamine—Nausea—Methotrexate—systemic scleroderma	0.00104	0.00104	CcSEcCtD
